[Form 4] Atlassian Corp Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, identified as CEO, co-founder and a >10% owner of Atlassian Corporation (TEAM), reported multiple sales of Class A common stock executed under a Rule 10b5-1 trading plan on 09/17/2025. The reporting lines list six separate dispositions totaling 7,665 shares sold at reported weighted-average prices per tranche ranging from about $172.12 to $176.72. After these transactions the report shows an indirect beneficial ownership of 68,985 Class A shares held through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. Each sale line includes a price range for the intra-day executions and an undertaking to provide detailed trade-level information on request.
Positive
- Trades executed under a Rule 10b5-1 plan, indicating pre-authorization and reducing concerns about opportunistic timing
- Reporting person retains material indirect ownership (68,985 Class A shares) via CBC Co Pty Limited as trustee
Negative
- Aggregate insider dispositions of 7,665 Class A shares on 09/17/2025, reducing the reporting person’s stake
- Multiple intra-day executions across price ranges up to $176.72 may be viewed by some investors as a liquidity-driven reduction in holdings
Insights
TL;DR: Insider sales followed a pre-established 10b5-1 plan; holdings remain material but sales reduce immediate insider stake.
The transactions were executed pursuant to an established Rule 10b5-1 plan, which generally mitigates concerns about opportunistic timing because trades are pre-authorized. The form discloses that the shares are held indirectly through a trustee structure, indicating continued centralized control of a material stake. From a governance perspective, documented plan-based sales are routine for senior executives and large holders, though investors may note the absolute reduction in beneficial shares.
TL;DR: Aggregate insider selling of 7,665 shares is notable in size but appears procedural under a trading plan; interpret as neutral-to-mildly negative signal.
The filing reports six dispositions with weighted-average tranche prices between approximately $171.39 and $176.72, totaling 7,665 shares sold. While the trades were executed under a 10b5-1 plan, which reduces informational timing concerns, the sales materially reduce the reporting person’s immediate indirect holdings to 68,985 shares. For investors, the sales are a liquidity event for the insider rather than a disclosed company performance issue.